Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,246,395
+$7,159,058 QoQ
Shares Held
370,458
+810.0% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Derivatives in ACAD
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$274,065
PutShares
16,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. ACAD ranks #34 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in ACAD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,246,395 | 370,458 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,087,337 | 40,709 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $274,065 | 16,500 | Put | Defined | 2025-08-27 | |
| 2025-03-31 | $790,436 | 47,588 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $3,400,493 | 185,313 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,811,048 | 572,890 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,787,166 | 848,441 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,656,095 | 1,008,983 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $373,498 | 20,200 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $8,674,498 | 277,052 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,313,810 | 159,012 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $4,112,734 | 218,530 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $7,786,067 | 475,921 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,970,351 | 494,702 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,834,869 | 199,623 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $711,659 | 30,491 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,919,285 | 115,550 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $1,743,651 | 32,616 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,649,011 | 209,673 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,205,757 | 66,139 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,351,946 | 79,336 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||